-
1841
Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53
Published 2025-01-01“…These agents can broadly be classified into six categories: the viral approach, direct modifiers of the p53 pathway, epigenetic modifiers of the p53 pathway, synthetic lethal agents, structural reactivators, and immune activating vaccines. Even these strategies have been met with limited success. …”
Get full text
Article -
1842
COVID-19: Malaysia's fight against this deadly virus
Published 2021-06-01“…This review discusses the alarming COVID-19 situation in Malaysia, the management strategies, and the vaccinations program. …”
Get full text
Article -
1843
Some statements on medical care in the "new normal" post-covid-19
Published 2023-03-01“…This has been possible thanks to the joint efforts of the whole of society, with its highest authorities ahead, the capacity and dedication of health professionals organized in a vigorous national health system, obtaining and applying effective native drugs and the massive immunization against SARS-COV-2, with our Cuban Abdala and Soberanas vaccines. Comments are made on a group of lessons learned during the pandemic, on the existence of many doubts and questions still unanswered, on the new risks -especially for the most vulnerable- including the so-called post-COVID syndrome, when events are held more massive outbreaks of different kinds, as well as alerting to the frequent appearance of new coronavirus’ variants and recent "waves" of patients in different countries. …”
Get full text
Article -
1844
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Published 2025-01-01“…This review examines various immunotherapy types, such as immune checkpoint inhibitors, adoptive T-cell therapies, and cancer vaccines, highlighting their cardiovascular risks. …”
Get full text
Article -
1845
<i>In vitro</i> and <i>in vivo</i> tropism and biodistribution of recombinant simian adenovirus type 25
Published 2024-11-01“…Recombinant adenoviruses are widely used in the development of vaccines for a variety of infectious diseases. Despite numerous clinical studies, only a few types of human (types 5 and 26) and simian (isolate Y25) adenoviruses are currently used to produce vaccine formulations. …”
Get full text
Article -
1846
Resurgence of Mumps among Lower Socioeconomic Class of Children in Ahmedabad: A Cross-sectional Study of 115 Cases in a Tertiary Care Center
Published 2024-05-01“…No patient was fully vaccinated for mumps. Out of the 15.6% (18 patients) admitted, two patients (1.7%) suffered from mumps complication of orchitis. …”
Get full text
Article -
1847
Public Health Ethics and Practice /
Published 2010Table of Contents: “…/ Jessica Datta and Anthony Kessell -- Constructing the obesity epidemic: loose science, money and public health / Alison Hann and Stephen Peckham -- Politics, ethics and evidence: immunisation and public health policy / Alison Hann and Stephen Peckham -- Avoiding mixed messages: HPV vaccines and the 'cure' for cervical cancer / Alison Hann and Stephen Peckham -- A call for clearer vaccine exemption typology to improve population health / Erica Sutton and Ross Upshur -- PART THREE. …”
View in OPAC
Book -
1848
Dynamic Roles of RNA and RNA Epigenetics in HTLV-1 Biology
Published 2025-01-01“…This review will highlight the dynamic roles of known RNA and post-transcriptional RNA epigenetic modifications within HTLV-1 biology, including viral <i>hbz</i>, long noncoding RNAs, microRNAs (miRNAs), transfer RNAs (tRNAs), R-loops, N6-methyladenosine (m<sup>6</sup>A) modifications, and RNA-based therapeutics and vaccines.…”
Get full text
Article -
1849
First isolation and characterization of SARS-CoV-2 from COVID-19 patient of North East India
Published 2023-01-01“…Virus isolation is of paramount importance for development of vaccines, in-vitro screening of antiviral compounds, pathogenesis studies, etc., Many cell lines were studied for amplification and replication of SARS-CoV-2 and Vero cells were found to be ideal cell lines for isolation. …”
Get full text
Article -
1850
Toll-Like Receptors and RIG-I-Like Receptors Play Important Roles in Resisting Flavivirus
Published 2018-01-01“…Even though people and animals are barraged with flavivirus infection every year, we have not invented either vaccines or antiviral for most flavivirus infections yet. …”
Get full text
Article -
1851
Coleopteran Antimicrobial Peptides: Prospects for Clinical Applications
Published 2012-01-01“…AMPs have potential applicability in the development of vaccines. Here, we review coleopteran AMPs, their potential impact on clinical medicine, and the molecular basis of immune defense.…”
Get full text
Article -
1852
Reformulation of Islamic Law in Indonesia: Study on Indonesian Ulama Council’s Fatwa
Published 2021-07-01“…Of the many fatwas that have been issued by the MUI, there are a number of fatwas that are formulated such as the fatwa of the pilgrimage and umrah pilgrimage, the initial determination of Ramadan, Shawwal, Zulhijjah, qibla direction, abortion, donation of social funds with prizes (SDSB), and the use of meningitis vaccines for hajj and umrah pilgrims. MUI reformulates the fatwa due to socio-cultural changes in the community and advances in science and technology. …”
Get full text
Article -
1853
Vectors, Hosts, and the Possible Risk Factors Associated with Severe Fever with Thrombocytopenia Syndrome
Published 2021-01-01“…SFTS has become a crucial public health concern because of the heavy burden, lack of vaccines, effective therapies, and high-fatality rate. …”
Get full text
Article -
1854
Continuous detection of Chikungunya Virus in a passive surveillance system in southern Thailand, 2012-2019.
Published 2025-01-01“…Chikungunya virus (CHIKV) infections are distributed across the globe, causing significant and, often, lasting morbidity. CHIKV vaccines are in development, but their evaluation is limited by the unpredictability of CHIKV transmission, which classically manifests as explosive epidemics separated by variable interepidemic periods. …”
Get full text
Article -
1855
Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
Published 2017-01-01“…Specific immunotherapies, including vaccines with autologous tumor cells and tumor antigen-specific monoclonal antibodies, are important treatments for PC patients. …”
Get full text
Article -
1856
MODERN ASPECTS OF LYSSAVIRUS CLASSIFICATION
Published 2018-04-01“…That's why further investigations of recovered rabies isolates and new vaccine development are of great importance.…”
Get full text
Article -
1857
Recurrent Herpetic Stromal Keratitis in Mice: A Model for Studying Human HSK
Published 2012-01-01“…We will document both differences and similarities that derive from this fundamental difference in these models with an eye towards possible vaccines and therapies that demonstrate promise in treating HSK.…”
Get full text
Article -
1858
The power of health economics and outcomes research (HEOR) in making decisions that matter
Published 2021-12-01“… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
Get full text
Article -
1859
Metal Complexes and Their Potential Therapeutic Role Against COVID-19: Recent Developments in Drug Designing
Published 2021-12-01“…Despite the development of various vaccines, there is still an urgent need to design novel treatments backed with safety data for fighting SARS-CoV-2 and its various mutants. …”
Get full text
Article -
1860
Innate Immune Memory: The Latest Frontier of Adjuvanticity
Published 2015-01-01“…This effect has been most extensively investigated for the tuberculosis vaccine strain Bacillus Calmette-Guérin (BCG). Epidemiological studies suggest that this vaccine is associated with a substantial reduction in overall child mortality that cannot be solely explained by prevention of the target disease but that it seems to rely on inducing resistance to other infections. …”
Get full text
Article